Cited by 69Autophagy in Disease and TherapyParkinson's Disease Mechanisms and TreatmentsUbiquitin and proteasome pathways

The DOI matches its Crossref record; the references it cites are not checked yet.

PINK1-dependent mitophagy is driven by the UPS and can occur independently of LC3 conversion

Open access
Rakovic, Aleksandar, Ziegler, Jonathan, Mårtensson, Christoph U., Prasuhn, Jannik, Shurkewitsch, Katharina, König, Peter, Paulson, Henry L., Klein, Christine·2019·Cell Death & Differentiation

Abstract

The Parkinson's disease (PD)-related ubiquitin ligase Parkin and mitochondrial kinase PINK1 function together in the clearance of damaged mitochondria. Upon mitochondrial depolarization, Parkin translocates to mitochondria in a PINK1-dependent manner to ubiquitinate outer mitochondrial membrane proteins. According to the current model, the ubiquitin- and LC3-binding adaptor protein SQSTM1 is recruited to mitochondria, followed by their selective degradation through autophagy (mitophagy). However, the role of the ubiquitin proteasome system (UPS), although essential for this process, still remains largely elusive. Here, we investigated the role of the UPS and autophagy by applying the potassium ionophore Valinomycin in PINK1-deficient human fibroblasts and isogenic neuroblastoma cell lines generated by CRISPR/Cas9. Although identical to the commonly used CCCP/FCCP in terms of dissipating the mitochondrial membrane potential and triggering complete removal of mitochondria, Valinomycin did not induce conversion of LC3 to its autophagy-related form. Moreover, FCCP-induced conversion of LC3 occurred even in mitophagy-incompetent, PINK1-deficient cell lines. While both stressors required a functional UPS, the removal of depolarized mitochondria persisted in cells depleted of LC3A and LC3B. Our study highlights the importance of the UPS in PINK1-/Parkin-mediated mitochondrial quality control. In contrast, activation of autophagy, monitored through conversion of LC3, is likely induced by depolarizing-agent-induced toxicity in a PINK1-/Parkin-independent manner.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41418-018-0219-z

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

The citation lists haven’t been fetched yet

References 38 · Cited by 69

Metadata

Authors
Rakovic, A., Ziegler, J., Mårtensson, C. U., Prasuhn, J., Shurkewitsch, K., König, P., Paulson, H. L., & Klein, C.
Affiliations
  • University of Lübeck (DE)
  • University of Freiburg (DE)
  • Michigan Medicine (US)
Corresponding author
Klein, Christine
Venue
Cell Death & Differentiation
Published
2018-10-30
Volume
26
Issue
8
Pages
1428-1441
ISSN
  • 1350-9047 (ISSN-L)
  • 1476-5403
OpenAlex
W2899375688
Cited by
69
References
38
Citations by year
2026: 4 · 2025: 12 · 2024: 6 · 2023: 9 · 2022: 11 · 2021: 13 · 2020: 9 · 2019: 5
FWCI
5.27
Type
journal article
Language
en
Open access
Locations
  • Cell Death and Differentiation (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • FreiDok plus (Universitätsbibliothek Freiburg) (submittedVersion)
Funders
  • Eli Lilly and Company
  • Hermann und Lilly Schilling-Stiftung für Medizinische Forschung
  • Deutsche Forschungsgemeinschaft (FOR2488)
  • Bundesministerium für Bildung und Forschung
  • Universität zu Lübeck
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
  • Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
Keywords
mitophagy, PINK1, Parkin, ubiquitin-proteasome system, LC3 conversion, mitochondrial quality control, mitochondrial depolarization, valinomycin, FCCP, p62, LC3A, LC3B, Parkinson's disease, autophagy
MeSH terms
PTEN-Induced Putative Kinase, Humans, Microtubule-Associated Proteins, Protein Kinases, Tumor Cells, Cultured, Ubiquitin, Proteasome Endopeptidase Complex, CRISPR-Cas Systems

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review